Showing results (171-180 of 530) with videos related to
Sort By:
Pageof 53
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2005
Creating oral squamous cancer cells: a cellular model of oral-esophageal carcinogenesisGitta Goessel, Michael Quante, William C Hahn, et al.European Urology Oncology|May 24, 2025
Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair DeficiencyRuben Raychaudhuri, Heather H Cheng, Roman Gulati, et al.Molecular Endocrinology (Baltimore, Md.)|October 29, 2010
CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylationVicki Gordon, Shriti Bhadel, Winfried Wunderlich, et al.Cell|June 11, 2013
HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxiaMatthew D Galbraith, Mary A Allen, Claire L Bensard, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profilingNikhil Wagle, Caroline Emery, Michael F Berger, et al.Clinical Genitourinary Cancer|February 25, 2014
Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancerAndrew C James, Franklin C Lee, Jason P Izard, et al.Science Signaling|May 17, 2012
MicroSCALE screening reveals genetic modifiers of therapeutic response in melanomaKris C Wood, David J Konieczkowski, Cory M Johannessen, et al.Oncogene|June 27, 2002
Immortalization and transformation of primary human airway epithelial cells by gene transferAnte S Lundberg, Scott H Randell, Sheila A Stewart, et al.Cancer Research|December 18, 2004
Androgen-induced differentiation and tumorigenicity of human prostate epithelial cellsRaanan Berger, Phillip G Febbo, Pradip K Majumder, et al.Genome Biology|August 23, 2023
Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethalJ Michael Krill-Burger, Joshua M Dempster, Ashir A Borah, et al.Pageof 53